AstraZeneca is seeking a US Executive Director for Early Assets to lead the development of medical strategies for early pipeline projects, integrating scientific insights into global plans. The ideal candidate will have extensive experience in the pharmaceutical industry, particularly in cardiovascular and metabolism, and will drive collaboration across multiple teams to ensure successful asset development and market launch.
Base: $331,874 to $497,810; Bonus/Equity: Short-term incentive bonus and equity-based long-term incentive program available; Benefits: 401(k), paid vacation, holidays, leaves, medical, dental, vision coverage
Must-have
Nice-to-have
Not specified